The CBD regulatory tracker offers a deep analysis of the regulations and proposals in over 50 countries, for nine major regulatory areas: hemp cultivation, processing, flower, extracts, food, cosmetics, vaping, pet food and import/export
A product from a CBD company has again been called out by the UK Advertising Standards Authority (ASA) for allegedly making unsubstantiated health and nutrition claims, but this time the claims were not about CBD
Barnaby Page, host of Tamarind Intelligence podcast, sits down with Michael Landl, director of the World Vapers’ Alliance, to unpack the major regulatory hurdles facing the e-cigarette sector in 2025 and beyond
Though it’s still early days, Switzerland could become the first European country to wholeheartedly legalise recreational cannabis, though that doesn’t mean that progress in Europe is speeding up
Join our host Barnaby Page as he sits down with Pablo Cano Trilla, regulatory director at Tamarind Intelligence, to explore the latest global updates on novel nicotine regulation.
Cannabis companies have been pushing the envelope of acceptable marketing and business practices by insinuating unproven benefits for their products while also looking to create the strongest goods possible
CannIntelligence presents the latest regulatory and market developments and trends in the global cannabis industry in slide deck format. The slide deck covers the latest developments from the fouth quarter of 2024
Join the Tamarind Intelligence leadership team for a compelling round-table discussion with four top industry experts. They’ll reflect on the major moments of 2024 in the reduced-risk nicotine world and share their insights for 2025.
Permitted THC levels in CBD products in the UK will be below Home Office drug law levels, according to the Food Standards Agency (FSA), though a specific amount has not been announced
Even the most general of positive statements can be construed as a health claim, according to the latest CBD ruling from the UK’s Advertising Standards Authority (ASA)
Rupert Wilson, managing director at Strategic Business Consulting and former Rothmans International tobacco expert, sits down with Tamarind Intelligence’s Tim Phillips to examine the influence of novel nicotine products on the performance and strategic direction of public tobacco firms.
This interactive and user-friendly dashboard shows the evolution of retail pricing in four of the largest medical cannabis markets in the world – Australia, Germany, Israel, and the UK
Join Tamarind Intelligence founder Tim Phillips and Editorial Director Barnaby Page as they explore the complexities of the illicit e-cigarette trade.
This snapshot offers an overview of Australia’s medical cannabis market and its regulations
This snapshot offers an overview of the Poland’s medical cannabis market and its regulations
This snapshot offers an overview of Israel’s medical cannabis market and its regulations
This snapshot offers an overview of Canada’s medical cannabis market and its regulations
CBD company websites must follow UK Food Standards Agency (FSA) guidelines – even though they are recommendations only – as demonstrated by two new rulings from the Advertising Standards Agency (ASA)
This snapshot offers an overview of Switzerland’s medical cannabis market and its regulations
This snapshot offers an overview of New Zealand’s medical cannabis market and its regulations
This snapshot offers an overview of the Czech Republic’s medical cannabis market and its regulations
This snapshot offers an overview of the UK’s medical cannabis market and its regulations
This snapshot offers an overview of Germany’s medical cannabis market and its regulations
Businesses that lead product innovation with what the consumer wants will be one step ahead when it comes to taking a next-generation product to market – particularly when making PMTAs in the US
Executives were taken aback by the enthusiasm vendors showed for a nicotine vape brand in Dubai with a US West Coast theme, even though it involves a product that the UAE only recently legalised
Vaping company Ispire has signed a 30-year global licensing agreement with Hidden Hills Club, a cannabinoid operation with wider lifestyle ambitions that will lead to the creation of Hidden Hills branded nicotine vaping products
CannIntelligence presents the latest regulatory and market developments and trends in the global cannabis industry in slide deck format. The slide deck covers the latest developments from the second quarter of 2024
On 1st July, cannabis clubs became allowed to operate under Germany’s new cannabis law, but this doesn’t mean that even the first already-licensed club will actually be able to start operations anytime soon
This report examines products offered online in the US that contain alternative active ingredients, such as intoxicating hemp-derived cannabinoids (IHDCs), kratom and mushrooms